- Report
- February 2026
- 70 Pages
South Korea
From €1188EUR$1,350USD£1,039GBP
- Report
- February 2026
- 70 Pages
Singapore
From €1188EUR$1,350USD£1,039GBP
- Report
- February 2026
- 70 Pages
Russia
From €1188EUR$1,350USD£1,039GBP
- Report
- February 2026
- 70 Pages
Netherlands
From €1188EUR$1,350USD£1,039GBP
- Report
- February 2026
- 70 Pages
Japan
From €1188EUR$1,350USD£1,039GBP
- Report
- February 2026
- 70 Pages
Italy
From €1188EUR$1,350USD£1,039GBP
- Report
- February 2026
- 70 Pages
China
From €1188EUR$1,350USD£1,039GBP
- Report
- February 2026
- 70 Pages
Brazil
From €1188EUR$1,350USD£1,039GBP
- Report
- February 2026
- 50 Pages
Global
From €2333EUR$2,650USD£2,040GBP
- Report
- November 2025
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- November 2025
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- November 2025
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- November 2025
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- November 2025
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- November 2025
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- November 2025
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- November 2025
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- November 2025
- 132 Pages
Global
From €836EUR$950USD£731GBP
- Report
- November 2025
- 132 Pages
Global
From €836EUR$950USD£731GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more